52,368 Shares in Surgery Partners, Inc. (NASDAQ:SGRY) Bought by NFJ Investment Group LLC

NFJ Investment Group LLC acquired a new position in shares of Surgery Partners, Inc. (NASDAQ:SGRY) in the third quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 52,368 shares of the company’s stock, valued at approximately $1,688,000.

A number of other institutional investors have also recently added to or reduced their stakes in the stock. DekaBank Deutsche Girozentrale grew its stake in shares of Surgery Partners by 102.0% in the first quarter. DekaBank Deutsche Girozentrale now owns 2,723 shares of the company’s stock worth $80,000 after purchasing an additional 1,375 shares in the last quarter. Wesbanco Bank Inc. grew its stake in shares of Surgery Partners by 53.4% in the second quarter. Wesbanco Bank Inc. now owns 39,363 shares of the company’s stock worth $936,000 after purchasing an additional 13,700 shares in the last quarter. SG Americas Securities LLC grew its stake in shares of Surgery Partners by 190.0% in the second quarter. SG Americas Securities LLC now owns 17,276 shares of the company’s stock worth $411,000 after purchasing an additional 11,318 shares in the last quarter. Raymond James & Associates grew its stake in shares of Surgery Partners by 6.8% in the second quarter. Raymond James & Associates now owns 68,872 shares of the company’s stock worth $1,638,000 after purchasing an additional 4,370 shares in the last quarter. Finally, MeadowBrook Investment Advisors LLC grew its stake in shares of Surgery Partners by 15.9% in the second quarter. MeadowBrook Investment Advisors LLC now owns 12,320 shares of the company’s stock worth $293,000 after purchasing an additional 1,690 shares in the last quarter.

Analysts Set New Price Targets

Several research firms have recently issued reports on SGRY. Macquarie reissued an “outperform” rating and issued a $34.00 price target on shares of Surgery Partners in a research note on Tuesday, November 19th. Royal Bank of Canada decreased their price target on Surgery Partners from $49.00 to $35.00 and set an “outperform” rating for the company in a research note on Wednesday, November 20th. StockNews.com lowered Surgery Partners from a “hold” rating to a “sell” rating in a report on Wednesday, August 7th. UBS Group started coverage on Surgery Partners in a report on Monday, October 14th. They issued a “buy” rating and a $38.00 price objective for the company. Finally, Cantor Fitzgerald restated an “overweight” rating and issued a $43.00 price objective on shares of Surgery Partners in a report on Friday, October 4th. One analyst has rated the stock with a sell rating, three have issued a hold rating and six have given a buy rating to the stock. According to MarketBeat, Surgery Partners currently has an average rating of “Moderate Buy” and an average price target of $37.38.

Surgery Partners Price Performance

Shares of NASDAQ SGRY opened at $22.52 on Thursday. Surgery Partners, Inc. has a 12 month low of $21.36 and a 12 month high of $36.92. The company has a quick ratio of 1.66, a current ratio of 1.80 and a debt-to-equity ratio of 0.99. The business has a fifty day simple moving average of $28.42 and a 200-day simple moving average of $28.17.

Surgery Partners (NASDAQ:SGRY) last announced its earnings results on Tuesday, November 12th. The company reported $0.19 EPS for the quarter, missing the consensus estimate of $0.25 by ($0.06). Surgery Partners had a negative net margin of 2.03% and a positive return on equity of 2.85%. The company had revenue of $770.40 million for the quarter, compared to analysts’ expectations of $768.99 million. During the same period in the prior year, the company earned $0.15 earnings per share. The company’s revenue for the quarter was up 14.3% on a year-over-year basis. On average, research analysts predict that Surgery Partners, Inc. will post 0.73 earnings per share for the current fiscal year.

Surgery Partners Company Profile

Surgery Partners, Inc, together with its subsidiaries, owns and operates a network of surgical facilities and ancillary services in the United States. The company provides ambulatory surgery centers and surgical hospitals that offer non-emergency surgical procedures in various specialties, including orthopedics and pain management, ophthalmology, gastroenterology, and general surgery.